Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image
- PMLiVE

Pharmaceutical Market Europe – April 2017

As Brexit begins, the April issue of PME offers advice on what pharma should do next and how the likely timelines shapeup

- PMLiVE

Pharmaceutical Market Europe – March 2017

This month in PME we take a look at employee engagement and the crucial role it plays in attracting and retaining talent, with those companies that get it right reaping...

- PMLiVE

Pharmaceutical Market Europe – February 2017

In the February issue of PME we look to balance the changes that are already the theme of 2017 with some much needed stability.

- PMLiVE

Pharmaceutical Market Europe – January 2017

The January issue of PME kicks off 2017 by analysing some of the seismic changes that are affect the industry over the next 12 months and beyond.

- PMLiVE

Pharmaceutical Market Europe – December 2016

This month we hear from the European Commissioner for Health on the burden European countries face from chronic diseases.

- PMLiVE

Pharmaceutical Market Europe – November 2016

This month we place behavioural change under the spotlight in a special section, where our expert contributors offer their thoughts on areas such as translating the theory into practice, applying...

- PMLiVE

Pharmaceutical Market Europe – October 2016

There’s no shortage of ambition at GlaxoSmithKline, whose chief immunology officer and senior vice president of their R&D pipeline Paul-Peter Tak we spoke to for this month’s executive interview.

- PMLiVE

Pharmaceutical Market Europe – September 2016

How confident are you in your country’s healthcare system? It’s the central issue for this month’s cover feature, which focuses on a global study of healthcare perceptions and offers up...

- PMLiVE

Pharmaceutical Market Europe – July/August 2016

Generating customer value, biosimilars, Brexit implications and immunotherapy directions

- PMLiVE

Pharmaceutical Market Europe – June 2016

Diversification, Brexit, rare diseases and the power of brand creativity

- PMLiVE

Pharmaceutical Market Europe – May 2016

The time for change is now, as our cover feature on medical affairs puts it, but there’s a transitional theme to much of this month’s PME

- PMLiVE

Pharmaceutical Market Europe – April 2016

Merck's Uta Kemmerich-Keil talks to PME about adding value, Amgen’s Sue Rees argues the case for pharmacovigilance and we assess access to health services in Europe.